Location History:
- Cambridge, GB (2006 - 2013)
- Hereford, GB (2019 - 2024)
Company Filing History:
3 out of 846 
2 out of 123 
1 out of 3,923 
Years Active: 2006-2024
Title: The Innovative Contributions of Marc O'Reilly
Introduction
Marc O'Reilly is a notable inventor based in Hereford, GB, recognized for his significant contributions to the field of medicinal chemistry. With a total of five patents to his name, O'Reilly has made strides in developing compounds that have the potential to impact cancer treatment.
Latest Patents
Among his latest patents, O'Reilly has developed benzolactam compounds that serve as protein kinase inhibitors. These compounds are specifically designed to inhibit ERK1/2 kinases, which are crucial in the treatment of ERK1/2-mediated conditions. The therapeutic applications of these compounds are particularly promising in the context of cancer treatment.
Career Highlights
O'Reilly has had a distinguished career, working with prominent companies in the pharmaceutical industry. He has been associated with Otsuka Pharmaceutical Company, Limited and Astex Therapeutics Limited, where he has contributed to various innovative projects and research initiatives.
Collaborations
Throughout his career, O'Reilly has collaborated with several professionals in the field, including Steven Howard and Alison Jo-Anne Woolford. These collaborations have further enriched his work and expanded the scope of his inventions.
Conclusion
Marc O'Reilly's innovative work in developing protein kinase inhibitors showcases his commitment to advancing medical science. His contributions have the potential to make a significant impact on cancer therapy and highlight the importance of continued research in this vital area.